Combination therapy with radiolabeled anti-cd20 antibody in...

Details Combination therapy with radiolabeled anti-cd20 antibody in... Combination therapy with radiolabeled anti-cd20 antibody in...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2568526

A method of treating B-cell lymphoma comprises administering to a patient a chemotherapeutic regimen, followed by treatment with a radiolabeled anti-CD20 antibody, wherein at the time of said treatment with said radiolabeled antibody said patient is not refractory to said chemotherapeutic regimen and has not relapsed.

L'invention concerne une méthode de traitement du lymphome B, consistant à administrer à un patient un régime chimiothérapeutique, suivi d'un traitement à base d'anticorps anti-CD20 radiomarqués. Au moment dudit traitement à base d'anticorps radiomarqués, le patient n'est pas réfractaire audit régime chimiothérapeutique et n'a pas subi une rechute.

Affiliated with

Also associated with

Rating

Combination therapy with radiolabeled anti-cd20 antibody in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy with radiolabeled anti-cd20 antibody in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy with radiolabeled anti-cd20 antibody in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1364594